Literature DB >> 2169829

Differentiation of bronchogenic carcinoma from secondary changes, obstructive pneumonitis and/or collapse by I-123 IMP lung imaging.

M Nakajo1, N Uchiyama, J Shimada, S Shinohara, A Iriki, Y Hirotsu, K Egawa, H Fukunaga, Y Norimatsu.   

Abstract

Serial lung images with N-isopropyl-p-[I-123]-iodoamphetamine (I-123 IMP) were obtained to assess the imaging findings and to clarify the lesion to uptake relationships in 74 lesions in 73 patients with various histological types of bronchogenic carcinoma. A decreased uptake area was observed in all 74 lesions in the initial one or two-min I-123 IMP image. The initial image was analogous to a Tc-99m MAA lung perfusion image in 70 patients in whom both lung imaging procedures were performed. The imaging findings changed following this initial phase. At 4 hr, the lesion was depicted as either areas of decreased uptake or increased uptake or a combination of the two. Comparison between the lesion findings in the 4-hr I-123 IMP images, radiograms and removed specimens revealed that areas of decreased uptake corresponded to the cancerous portions of the lung mass or pleural effusion and areas of increased uptake corresponded to inflammatory portions including obstructive pneumonitis and/or collapse. Thus, the 4-hr I-123 IMP lung images can be used to discriminate the cancerous portion from associated secondary changes, obstructive pneumonitis and/or collapse.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169829     DOI: 10.1007/BF03165653

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  16 in total

1.  [Serial lung imaging with 123I-IMP in localized pulmonary lesions].

Authors:  M Nakajo; J Shimada; M Shimozono; N Uchiyama; Y Hiraki; S Shinohara
Journal:  Kaku Igaku       Date:  1988-05

2.  [The study of the lung accumulation of I-123 IMP by the broncho-alveolar lavage].

Authors:  M Itasaka; H Ikeda; N Yakuwa; S Kato; K Takahashi; S Yasui
Journal:  Kaku Igaku       Date:  1989-02

3.  [Evaluation of the lung uptake of 123I-IMP by bronchoalveolar lavage].

Authors:  S Kosuda; S Kawahara; K Tamura; A Kubo; S Hashimoto
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  1989-04-25

4.  Differentiation of proximal bronchogenic carcinoma from postobstructive lobar collapse by magnetic resonance imaging. Comparison with computed tomography.

Authors:  J Tobler; R G Levitt; H S Glazer; J Moran; E Crouch; R G Evens
Journal:  Invest Radiol       Date:  1987-07       Impact factor: 6.016

5.  Regional cerebral perfusion imaging in the elderly.

Authors:  N K Coni; E P Wraight; R W Barber
Journal:  Age Ageing       Date:  1984-07       Impact factor: 10.668

6.  Cerebral perfusion imaging with iodine 123-labeled amines.

Authors:  B L Holman; T C Hill; J F Polak; R G Lee; H D Royal; D H O'Leary
Journal:  Arch Neurol       Date:  1984-10

7.  Initial experience with SPECT (single-photon computerized tomography) of the brain using N-isopropyl I-123 p-iodoamphetamine: concise communication.

Authors:  T C Hill; B L Holman; R Lovett; D H O'Leary; D Front; P Magistretti; R E Zimmerman; S Moore; M E Clouse; J L Wu; T H Lin; R M Baldwin
Journal:  J Nucl Med       Date:  1982-03       Impact factor: 10.057

8.  Delineation of epileptic focus by single photon emission tomography.

Authors:  P Magistretti; R Uren; H Blume; D Schomer; H Royal
Journal:  Eur J Nucl Med       Date:  1982

9.  Measurement of metabolic extraction of tracers in the lung using a multiple indicator dilution technique.

Authors:  J Rahimian; E C Glass; J J Touya; S F Akber; L S Graham; L R Bennett
Journal:  J Nucl Med       Date:  1984-01       Impact factor: 10.057

10.  Increased accumulation of iodine-123-IMP in the pulmonary inflammatory lesion surrounding a lung cancer.

Authors:  M Nakajo; N Uchiyama; Y Hiraki; Y Miyata; A Iriki; Y Hirotsu; J Wakimoto; Y Norimatsu
Journal:  Ann Nucl Med       Date:  1988-05       Impact factor: 2.668

View more
  4 in total

1.  New design of N-isopropyl-p-[123I]iodoamphetamine (123I-IMP) lung imaging in the patient with lung cancer.

Authors:  E Tanaka; M Mishima; K Kawakami; N Sakai; N Sugiura; T Taniguchi; M Ohi; H Itoh; K Kuno
Journal:  Ann Nucl Med       Date:  1995-11       Impact factor: 2.668

2.  On clinical usefulness of Tl-201 scintigraphy for the management of malignant soft tissue tumors.

Authors:  S Terui; T Terauchi; H Abe; H Fukuma; Y Beppu; K Chuman; R Yokoyama
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

3.  I-123 IMP scintigraphy in two patients with primary pulmonary malignant lymphoma.

Authors:  K Suga; K Nishigauchi; M Sadanaga; N Kume; H Uchisako; T Matsumoto; T Nakanishi
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

4.  N-isopropyl-p-iodoamphetamine receptors in normal and cancerous tissue of the human lung.

Authors:  E Tanaka; M Mishima; K Kawakami; N Sakai; N Sugiura; T Taniguchi; K Kuno
Journal:  Eur J Nucl Med       Date:  1993-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.